TRS(TRS)
TRS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $679M | $714M |
| Low | $676M | $712M |
| High | $684M | $715M |
| EBITDA Avg | $103M | $108M |
| Low | $102M | $108M |
| High | $103M | $108M |
| EBIT Avg | $51M | $54M |
| Low | $51M | $54M |
| High | $52M | $54M |
| Net Income Avg | $68M | $89M |
| Low | $68M | $88M |
| High | $69M | $89M |
| EPS Avg | $1.67 | $2.17 |
| Low | $1.66 | $2.16 |
| High | $1.68 | $2.18 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $174M | $159M | $175M | $190M | $180M | $169M |
| Low | $172M | $157M | $174M | $188M | $178M | $167M |
| High | $175M | $160M | $177M | $191M | $181M | $170M |
| EBITDA Avg | $26M | $24M | $26M | $29M | $27M | $25M |
| Low | $26M | $24M | $26M | $28M | $27M | $25M |
| High | $26M | $24M | $27M | $29M | $27M | $26M |
| EBIT Avg | $13M | $12M | $13M | $14M | $14M | $13M |
| Low | $13M | $12M | $13M | $14M | $13M | $13M |
| High | $13M | $12M | $13M | $14M | $14M | $13M |
| Net Income Avg | $19M | $16M | $19M | $21M | $21M | $20M |
| Low | $19M | $16M | $19M | $21M | $21M | $20M |
| High | $20M | $16M | $19M | $21M | $21M | $20M |
| EPS Avg | $0.52 | $0.43 | $0.51 | $0.56 | $0.56 | $0.54 |
| Low | $0.50 | $0.42 | $0.50 | $0.55 | $0.55 | $0.53 |
| High | $0.54 | $0.43 | $0.51 | $0.57 | $0.57 | $0.55 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |